ELF

The Enhanced Liver Fibrosis (ELF™) test is a noninvasive blood (serum) lab test, which combines three direct ECM biomarkers: hyaluronic acid (HA), procollagen III aminoterminal peptide (PIIINP), and tissue inhibitor of matrix metalloproteinase 1 (TIMP-1), into a validated composite score. The ELF™ score helps clinicians and researchers assess fibrosis severity and risk in metabolic and chronic liver diseases, including MASLD/NAFLD.

Would you like to learn more? Contact us!

Your scientific area Select areaCardiologyDermatologyGastroenterologyHepatologyNephrologyNeurologyObesityPulmonologyRheumatologyMulti-organ/Other Your request Select requestGeneral inquiryBiomarkersLaboratorySomething else

First name Last name

Email Company/Organization (optional) Phone (optional) Your message (optional) Nordic Bioscience ApS and its non-profit partner, The Extracellular Matrix Pharmacology Congress, can contact me by email with news on research, events, products, and similar. I can always withdraw my consent at any time. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.